|
ARTICLE
Correlation of clinical and immunological data
in a metastatic melanoma patient with heterogeneous
tumor responses to ipilimumab therapy
Jianda Yuan, David B. Page, Geoffrey Y. Ku, Yanyun
Li, Zhenyu Mu, Charlotte Ariyan, Humilidad F. Gallardo,
Ruth-Ann Roman, Agnes I. Heine, Stephanie L. Terzulli,
Sacha Gnjatic, Gerd Ritter, Achim A. Jungbluth, James
P. Allison, Lloyd J. Old and Jedd D. Wolchok
Cancer Immunity 10 : 1 (7 January 2010) >Abstract
>Full text
>PDF
>Erratum
ARTICLE
HAGE, a cancer/testis antigen expressed at the
protein level in a variety of cancers
Morgan G. Mathieu, Adam J. Linley, Stephen P. Reeder,
Cécile Badoual, Eric Tartour, Robert C. Rees
and Stéphanie E. B. McArdle
Cancer Immunity 10 : 2 (11 January 2010) >Abstract
>Full text
>PDF
ARTICLE
Possible significance of differences in proportions
of cytotoxic T cells and B-lineage cells in the tumour-infiltrating
lymphocytes of typical and atypical medullary carcinomas
of the breast
Kok Haw Jonathan Lim, Premasiri Upali Telisinghe,
Muhd Syafiq Abdullah and Ranjan Ramasamy
Cancer Immunity 10 : 3 (22 January 2010) >Abstract
>Full text
>PDF
ARTICLE
Cellular immune responses against CT7 (MAGE-C1)
and humoral responses against other cancer-testis
antigens in multiple myeloma patients
Nikoletta Lendvai, Sacha Gnjatic, Erika Ritter, Michael
Mangone, Wayne Austin, Karina Reyner, David Jayabalan,
Ruben Niesvizky, Sundar Jagannath, Nina Bhardwaj,
Selina Chen-Kiang, Lloyd J. Old and Hearn Jay Cho
Cancer Immunity 10 : 4 (29 January 2010) >Abstract
>Full text
>PDF
ERRATUM
Erratum: Correlation of clinical and immunological
data in a metastatic melanoma patient with heterogeneous
tumor responses to ipilimumab therapy
Jianda Yuan, David B. Page, Geoffrey Y. Ku, Yanyun
Li, Zhenyu Mu, Charlotte Ariyan, Humilidad F. Gallardo,
Ruth-Ann Roman, Agnes I. Heine, Stephanie L. Terzulli,
Sacha Gnjatic, Gerd Ritter, Achim A. Jungbluth, James
P. Allison, Lloyd J. Old and Jedd D. Wolchok
Cancer Immunity 10 : 5 (24 February 2010) >Full text
>PDF
ARTICLE
BORIS/CTCFL expression is insufficient for cancer-germline
antigen gene expression and DNA hypomethylation in
ovarian cell lines
Anna Woloszynska-Read, Smitha R. James, Chajoun Song,
Boquan Jin, Kunle Odunsi and Adam R. Karpf
Cancer Immunity 10 : 6 (23 July 2010) >Abstract
>Full text
>PDF
ARTICLE
High efficiency CD91- and LOX-1-mediated re-presentation
of gp96-chaperoned peptides by MHC II molecules
Toyoshi Matsutake, Tatsuya Sawamura and Pramod K.
Srivastava
Cancer Immunity 10 : 7 (2 August 2010) >Abstract
>Full text
>PDF
ARTICLE
A panel of cancer-testis genes exhibiting broad-spectrum
expression in haematological malignancies
Amanda P. Liggins, Seah H. Lim, Elizabeth J. Soilleux,
Karen Pulford and Alison H. Banham
Cancer Immunity 10 : 8 (23 August 2010) >Abstract
>Full text
>PDF
ARTICLE
Ipilimumab efficacy and safety in patients with
advanced melanoma: a retrospective analysis of HLA
subtype from four trials
Jedd D. Wolchok, Jeffrey S. Weber, Omid Hamid, Celeste
Lebbé, Michele Maio, Dirk Schadendorf, Veerle
de Pril, Kevin Heller, Tai-Tsang Chen, Ramy Ibrahim,
Axel Hoos and Steven J. O'Day
Cancer Immunity 10 : 9 (20 October 2010) >Abstract
>Full text
>PDF
ARTICLE
Lysis of aminobisphosphonate-sensitized MCF-7 breast tumor cells by Vγ9Vδ2 T cells
Swati Dhar and Shubhada V. Chiplunkar
Cancer Immunity 10 : 10 (12 November 2010) >Abstract
>Full text
>PDF
ARTICLE
Blockade of cytotoxic T-lymphocyte antigen-4 by
ipilimumab results in dysregulation of gastrointestinal
immunity in patients with advanced melanoma
David Berman, Susan M. Parker, Jonathan Siegel, Scott
D. Chasalow, Jeffrey Weber, Susan Galbraith, Stephan
R. Targan and Hanlin L. Wang
Cancer Immunity 10 : 11 (24 November 2010) >Abstract
>Full text
>PDF
|